Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Tickers AMRX CVS NEWS NVS
Tags CVS Health Market News Large Cap
From Benzinga
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Tickers GS LLY MRK NVDA
Tags NVS LLY WMT
From Motley Fool
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Tickers BMY CI CNC CVS
Tags IYH JNJ IHF
From Benzinga
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Tickers AMGN AZN BMY EXEL
Tags Biotech NVS JNJ
From Benzinga
Novartis Touts Encouraging Data From Late-Stage Study For Fabhalta In Rare Type Of Blood Disorder
Tickers AZN NEWS NVS PTCT
Tags Benzinga Stories That Matter Health Care
From Benzinga
Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst
Tickers JANX NEWS NVS
Tags NVS JANX Biotech
From Benzinga
PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program
Tickers NEWS NVS PTCT
Tags News Briefs General
From Benzinga
2 Dividend Stocks to Buy and Hold Forever
Tickers NVS V
Tags NVS V Market News
From Motley Fool
Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Tickers NEWS NVS
Tags General Briefs Large Cap
From Benzinga
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
Tickers ARKG NEWS NVS SDGR
Tags Briefs General Market News
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags AMGN Trading Ideas Stories That Matter
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags Penny Stocks Health Care BMY
From Benzinga
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript
Tickers NVS
Tags Market News Recent Press Releases NVS
From Motley Fool
Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts 2024 Outlook
Tickers NEWS NVS
Tags Top Stories News Guidance
From Benzinga
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
Tickers GLUE NEWS NVS
Tags NVS GLUE Equities
From Benzinga
3 Absurdly Cheap Stocks That Pay High Dividends
Tickers GILD MRK NVS
Tags Recent Press Releases Market News GILD
From Motley Fool
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
Tickers CTLT NEWS NVO NVS
Tags Benzinga NVO Stories That Matter
From Benzinga
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
Tickers NEWS NVS SNY
Tags NVS Equities Biotech
From Benzinga
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
Tickers NVS
Tags Recent Press Releases Market News NVS
From Motley Fool
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
Tickers ALPMF ALPMY APLS NEWS
Tags Analyst Ratings Biotech ALPMY
From Benzinga
Looking Into Novartis's Recent Short Interest
Tickers NVS
Tags Market News Benzinga Trading Ideas
From Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
Tickers ABBV NVS
Tags Market News Recent Press Releases ABBV
From Motley Fool
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
Tickers NEWS NVS OKUR
Tags Trading Ideas Benzinga OKUR
From Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
Tickers AZN LLY NEWS NVO
Tags Market News Large Cap General
From Benzinga
Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
Tickers INCY NEWS NVS
Tags Benzinga Trading Ideas Stories That Matter
From Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Tickers NEWS NVS SNY
Tags Benzinga SNY FDA
From Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
Tickers ACET ANIP NEWS NVS
Tags Downgrades Market News News
From Benzinga
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
Tickers APP ASO ATOS CAC
Tags News PT Changes GME
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags General Briefs Movers
From Benzinga
Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
Tickers NEWS NVO NVS
Tags NVS Analyst Ratings why it's moving
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.